Theravance


Theravance’s (TBPH) COPD Drug Wins FDA Approval

Today, the FDA approved Theravance’s (TBPH) Yupelri (revefenacin) inhalation solution for the treatment of COPD. Thervance and Mylan (MYL) are partnered on the opportunity.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts